v3.26.1
COMMON STOCK AND STOCK OPTIONS (Tables)
12 Months Ended
Dec. 31, 2025
COMMON STOCK AND STOCK OPTIONS [Abstract]  
Stock Option Activity
Transactions with respect to the Company’s stock option plans for the years ended December 31, 2025 and 2024 are as follows:
 
           
     Number
of
Shares
    Weighted
Average
Exercise Price
 
           
Outstanding at January 1, 2024
  714,050   $2.14 
Granted
  76,850    2.21 
Expired
  (3,000   2.90 
Forfeited
  (27,750   1.94 
           
Outstanding at December 31, 2024
  760,150   $2.15 
Granted
  172,700    2.60 
Expired
  (29,625   2.21 
Forfeited
  (62,215   2.24 
Exercised
  (45,100   2.15 
           
Outstanding at December 31, 2025
  795,910   $2.24 
Fair Value of Weighted Average Assumptions used in the Valuation of Stock Options The fair value of options at date of grant was estimated using the Black-Scholes model with the following weighted average assumptions:
     2025      2024  
               
Risk-free interest rate
   4.07 %   4.20 %
Expected volatility factor
   61.16 %    63.81 %
Expected dividends
  0.00   0.00
Expected life of the option (years)
  6.00   6.00
Stock Options Outstanding by Price Range
The following table summarizes information about the Company’s stock options outstanding as of December 31, 2025:
 
                 
   
Options Outstanding
 
Options Exercisable
 
Range of Exercise Prices
 
Number
Outstanding
 
Weighted Average
Remaining
Contractual Life
(in years)
 
Weighted
Average
Exercise Price
 
Number
Exercisable
 
Weighted
Average
Exercise Price
 
                       
$1.00 - $ 2.00
   
280,510
   
3.90
 
$
1.58
   
193,110
 
$
1.53
 
$2.01 - $ 3.00
   
460,400
   
4.94
 
$
2.53
   
146,775
 
$
2.57
 
$3.01 - $ 6.00
   
55,000
   
6.67
 
$
3.16
   
5,000
 
$
4.00
 
                                 
     
795,910
   
4.69
 
$
2.24
   
344,885
 
$
2.01
 
Non-vested Options
A summary of the Company’s non-vested options and changes during the year ended December 31, 2025 is presented below:
 
         
    Number
of Shares
 
     Weighted
Average
Grant Date
Fair Value
 
           
Non-vested, beginning of year
  405,910   $1.39 
Granted
  172,700    2.60 
Vested
  (65,150   1.82 
Expired or forfeited
  (62,435   2.24 
           
Non-vested, end of year
  451,025   $2.41 
Stock-based Compensation Expense for Stock Options The following table summarizes the stock-based compensation expense for stock options that was recorded in the Company’s results of operations in accordance with ASC 718 for the years ended December 31, 2025 and 2024 as follows:
               
   
2025
   
2024
 
               
Data and product costs
  $ 32,531    $ 31,619 
Selling, general and administrative expenses
    64,950      67,339 
               
    $ 97,481    $ 98,958